LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)

LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of EGFR+ NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III EGFR-Mutated NSCLC Compared to Placebo (LAURA, NCT03521154)

Faustine X Luo,1,2 Zhaohui Arter,1,2 Sai-Hong Ignatius Ou,1,2 Misako Nagasaka1– 3 1Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USA; 2University of California Irvine School of Medicine, Orange, CA, 92868, USA; 3St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence:...

Full description

Saved in:
Bibliographic Details
Main Authors: Luo FX, Arter Z, Ou SI, Nagasaka M
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Lung Cancer: Targets and Therapy
Subjects:
stage iii
chemoradiation
consolidation therapy
epidermal growth factor receptor
tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/laura-completes-the-osimertinib-treatment-jigsaw-puzzle-of-egfr-nsclc--peer-reviewed-fulltext-article-LCTT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/laura-completes-the-osimertinib-treatment-jigsaw-puzzle-of-egfr-nsclc--peer-reviewed-fulltext-article-LCTT

Similar Items